Clinical Trial Update: B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update of B-MAD chemotherapy in newly diagnosed Extranodal NK/T-cell Lymphoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma

Drugs mentioned

• B-MAD chemotherapy (B-MAD)

Snippet

Sponsor: The Thai Lymphoma Study Group | Conditions: Extranodal NK/T-cell Lymphoma | Phase 1, Phase 2 | Status: COMPLETED